Viewing Study NCT06756035

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:07 PM
Ignite Modification Date: 2026-02-03 @ 4:43 AM
Study NCT ID: NCT06756035
Status: RECRUITING
Last Update Posted: 2025-07-31
First Post: 2024-12-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: CT-95 in Advanced Cancers Associated With Mesothelin Expression
Sponsor: Context Therapeutics Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mesothelin-Expressing Tumors View
None Epithelial Ovarian Cancer View
None Malignant Pleural Mesothelioma, Advanced View
None Malignant Peritoneal Mesothelioma, Advanced View
None Pancreatic Adenocarcinoma Advanced or Metastatic View
None Lung Adenocarcinoma Metastatic View
None Cholangiocarcinoma Advanced View
None Cholangiocarcinoma Non-resectable View
None Mesothelin-expressing Advanced Cancers View
None Mesothelin-positive Advanced Malignant Solid Tumors View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase 1 Dose Escalation Study View
None CT-95 View
None Advanced, recurrent cancers View
None Unresectable, metastatic cancers View
None Cancers associated with mesothelin expression View